Page last updated: 2024-11-08

roseofungin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

roseofungin: polyene antibiotic produced by a Streptomyces strain; Russian drug [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID197137
MeSH IDM0053678

Synonyms (4)

Synonym
roseofungin
12687-98-8
DTXSID101106214
14,16,18,20,24,26-hexahydroxy-3-methyl-36-(1-methylethyl)oxacyclohexatriaconta-3,5,7,9,11,13-pentaene-2,22,28-trione

Research Excerpts

Overview

Roseofungin is a pentaene antibiotic of the subgroup of carbonyl conjugated pentaenes.

ExcerptReferenceRelevance
"Roseofungin is a pentaene antibiotic of the subgroup of carbonyl conjugated pentaenes. "( [Structure of the pentaene antibiotic roseofungin].
Daurenbekova, AS; Iakovlev, AA; Morgunova, AF; Shenin, IuD; Vetlugina, LA, 1986
)
1.98
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (70.00)18.7374
1990's3 (30.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.04 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]